Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression

Cancer Investigation

Volumn 28, Issue 9, 2010, Pages 885-895

  Jiang, Yanlin ^a   Zhou, Shaoyu ^a   Sandusky, George E ^a   Kelley, Mark R ^a   Fishel, Melissa L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APE1 Ref 1; cell cycle; Pancreatic cancer; siRNA

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; REDOX EFFECTOR FACTOR 1; SMALL INTERFERING RNA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; G2 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; OXIDATION-REDUCTION; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE;

EID: 77958001097     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.512816     Document Type: Article

References (49)

1. Moore, M. J. Chemotherapy in pancreatic carcinoma. Current Oncol 2003, 5, s24-s26.
2. Duffy, J. P.; Eibl, G.; Reber, H. A.; Hines, O. J. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2003, 2, 12.
3. Zou, G. M.; Maitra, A. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther 2008, 7, 2012-2021.
4. Evans, A. R.; Limp-Foster, M.; Kelley, M. R. Going APE over ref-1. Mutat Res 2000, 461, 83-108.
5. Tell, G.; Quadrifoglio, F.; Tiribelli, C.; Kelley, M. R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11, 601-620.
6. Xie, K.; Wei, D.; Huang, S. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006, 17, 147-156.
7. Ray, S.; Lee, C.; Hou, T.; Bhakat, K. K.; Brasier, A. R. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol Endocrinol 2010, 24, 391-401.
8. Luo, M.; Delaplane, S.; Jiang, A.; Reed, A.; He, Y.; Fishel, M.; Nyland RL, 2nd.; Borch, R. F.; Qiao, X.; Georgiadis, M. M.; Kelley, M. R. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 2008, 10, 1853-1867.
9. Zou, G. M.; Karikari, C.; Kabe, Y.; Handa, H.; Anders, R. A.; Maitra, A. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol 2009, 219, 209-218.
10. Bhakat, K. K.; Mantha, A. K.; Mitra, S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 2009, 11, 621-638.
11. Bapat, A.; Fishel, M.; Kelley, M. R. Going Ape as an approach to cancer therapeutics. Antioxid Redox Signal 2009, 11, 651-668.
12. Fishel, M. L.; Kelley, M. R. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Molecular Aspects of Medicine 2007, 28, 375-395.
13. Jiang, Y.; Guo, C.; Vasko, M. R.; Kelley, M. R. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 2008, 68, 6425-6434.
14. Walker, L. J.; Craig, R. B.; Harris, A. L.; Hickson, I. D. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 1994, 22, 4884-4889.
15. Lau, J. P.; Weatherdon, K. L.; Skalski, V.; Hedley, D. W. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 2004, 91, 1166-1173.
16. Wang, D.; Luo, M.; Kelley, M. R. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004, 3, 679-686.
17. Fan, Z.; Beresford, P. J.; Zhang, D.; Xu, Z.; Novina, C. D.; Yoshida, A.; Pommier, Y.; Lieberman, J. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 2003, 4, 145-153.
18. Fishel, M. L.; He, Y.; Reed, A. M.; Chin-Sinex, H.; Hutchins, G. D.; Mendonca, M. S.; Kelley, M. R. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 2008, 7, 177-186.
19. Moore, D. H.; Michael, H.; Tritt, R.; Parsons, S. H.; Kelley, M. R. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 2000, 6, 602-609.
20. Tell, G.; Pellizzari, L.; Pucillo, C.; Puglisi, F.; Cesselli, D.; Kelley, M. R.; Di Loreto, C.; Damante, G. TSH controls Ref-1 nuclear translocation in thyroid cells. J Mol Endocrinol 2000, 24, 383-390.
21. Hansen, W. K.; Deutsch, W. A.; Yacoub, A.; Xu, Y.; Williams, D. A.; Kelley, M. R. Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1 (Ref 1)) DNA repair proteins. J Biol Chem 1998, 273, 756-762.
22. Robertson, K. A.; Hill, D. P.; Xu, Y.; Liu, L.; Van Epps, S.; Hockenbery, D. M.; Park, J. R.; Wilson, T. M.; Kelley, M. R. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 1997, 8, 443-449.
23. Xu, Y.; Moore, D. H.; Broshears, J.; Liu, L.; Wilson, T. M.; Kelley, M. R. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 1997, 17, 3713-3719.
24. Fishel, M. L.; Newell, D. R.; Griffin, R. J.; Davison, R.; Wang, L. Z.; Curtin, N. J.; Zuhowski, E. G.; Kasza, K.; Egorin, M. J.; Moschel, R. C.; Dolan, M. E. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity. J Pharmacol Exp Ther 2005, 312, 206-213.
25. Arris, C. E.; Boyle, F. T.; Calvert, A. H.; Curtin, N. J.; Endicott, J. A.; Garman, E. F.; Gibson, A. E.; Golding, B. T.; Grant, S.; Griffin, R. J.; Jewsbury, P.; Johnson, L. N.; Lawrie, A. M.; Newell, D. R.; Noble, M. E.; Sausville, E. A.; Schultz, R.; Yu, W. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem 2000, 43, 2797-2804.
26. Dolan, M. E.; Chae, M. Y.; Pegg, A. E.; Mullen, J. H.; Friedman, H. S.; Moschel, R. C. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase. Cancer Res 1994, 54, 5123-5130.
27. Dolan, M. E.; Roy, S. K.; Fasanmade, A. A.; Paras, P. R.; Schilsky, R. L.; Ratain, M. J. O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings. J Clin Oncol 1998, 16, 1803-1810.
28. Szabados, E.; Fischer, G. M.; Gallyas, F., Jr.; Kispal, G.; Sumegi, B. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Radic Biol Med 1999, 27, 1103-1113.
29. Tell, G.; Damante, G.; Caldwell, D.; Kelley, M. R. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 2005, 7, 367-384.
30. Chattopadhyay, R.; Wiederhold, L.; Szczesny, B.; Boldogh, I.; Hazra, T. K.; Izumi, T.; Mitra, S. Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res 2006, 34, 2067-2076.
31. Anderson, S.; Bankier, A. T.; Barrell, B. G.; de Bruijn, M. H.; Coulson, A. R.; Drouin, J.; Eperon, I. C.; Nierlich, D. P.; Roe, B. A.; Sanger, F.; Schreier, P. H.; Smith, A. J.; Staden, R.; Young, I. G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290, 457-465.
32. Fung, H.; Demple, B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 2005, 17, 463-470.
33. Vascotto, C.; Cesaratto, L.; Zeef, L. A.; Deganuto, M.; D'Ambrosio, C.; Scaloni, A.; Romanello, M.; Damante, G.; Taglialatela, G.; Delneri, D.; Kelley, M. R.; Mitra, S.; Quadrifoglio, F.; Tell, G. Genomewide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009, 9, 1058-1074.
34. Chow, J. P.; Siu, W. Y.; Ho, H. T.; Ma, K. H.; Ho, C. C.; Poon, R. Y. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 2003, 278, 40815-40828.
35. Dekoj, T.; Lee, S.; Desai, S.; Trevino, J.; Babcock, T. A.; Helton, W. S.; Espat, N. J. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. J Surg Res 2007, 139, 106-112.
36. Ujiki, M. B.; Ding, X. Z.; Salabat, M. R.; Bentrem, D. J.; Golkar, L.; Milam, B.; Talamonti, M. S.; Bell RH, Jr.; Iwamura, T.; Adrian, T. E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 2006, 5, 76.
37. Moore, M. J.; Feld, R.; Hedley, D.; Oza, A.; Siu, L. L. A phase II study of temozolomide in advanced untreated pancreatic cancer. Invest New Drugs 1998, 16, 77-79.
38. Burris HA, 3rd. Recent updates on the role of chemotherapy in pancreatic cancer. Semin Oncol 2005, 32, 1-3.
39. Kern, S.; Tempero, M.; Conley, B.; et al. Pancreatic Cancer: An Agenda for Action. Bethesda, MD: National Cancer Institute, 2001.
40. Yang, S.; Misner, B.; Chiu, R.; Meyskens FL, Jr. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis 2007, 28, 2382-2390.
41. Mohiuddin, M.; Chendil, D.; Dey, S.; Alcock, R. A.; Regine, W.; Mohiuddin, M.; Ahmed, M. M. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. Anticancer Res 2002, 22, 825-830.
42. Yu, J.; Zhang, L.; Hwang, P. M.; Rago, C.; Kinzler, K. W.; Vogelstein, B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999, 96, 14517-14522.
43. Grau, A. M.; Zhang, L.; Wang, W.; Ruan, S.; Evans, D. B.; Abbruzzese, J. L.; Zhang, W.; Chiao, P. J. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997, 57, 3929-3934.
44. Ewald, B.; Sampath, D.; Plunkett, W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol Cancer Ther 2007, 6, 1239-1248.
45. Sorensen, C. S.; Syljuasen, R. G.; Falck, J.; Schroeder, T.; Ronnstrand, L.; Khanna, K. K.; Zhou, B. B.; Bartek, J.; Lukas, J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3, 247-258.
46. Marcelino, L. A.; Thilly, W. G. Mitochondrial mutagenesis in human cells and tissues. Mutat Res 1999, 434, 177-203.
47. Luo, M.; He, H.; Kelley, M. R.; Georgiadis, M. Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal 2010, 12, 1247-1269.
48. Liu, L.; Gerson, S. L. Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Curr Opin Investig Drugs 2004, 5, 623-627.
49. Madhusudan, S.; Smart, F.; Shrimpton, P.; Parsons, J. L.; Gardiner, L.; Houlbrook, S.; Talbot, D. C.; Hammonds, T.; Freemont, P. A.; Sternberg, M. J.; Dianov, G. L.; Hickson, I. D. Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Res 2005, 33, 4711-4724.